| Dr David Bradley Jenks Jr, PHD, LMFT | |
|
2121 N 1700 W, Layton, UT 84041-8803 | |
| (801) 773-4840 | |
| Not Available |
| Full Name | Dr David Bradley Jenks Jr |
|---|---|
| Gender | Male |
| Speciality | Marriage & Family Therapist |
| Location | 2121 N 1700 W, Layton, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255876777 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | (* (Not Available)) | Primary |
| Entity Name | Tanner Memorial Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447239355 PECOS PAC ID: 4284547985 Enrollment ID: O20031110000132 |
News Archive
Tibotec Therapeutics announced today that the U.S. Food and Drug Administration (FDA) has approved a labeling update for PREZISTA® (darunavir) tablets to include 96-week data from the ARTEMIS and TITAN studies.
The worldwide safety experience of endoscopist-administered propofol sedation now exceeds 600,000 patients. The low rate of serious adverse events underscores the safety of nonanesthesiologist-administered propofol (NAAP) for gastrointestinal (GI) procedures, provided that it is administered by a team of individuals who have received training specific to the administration of propofol according to the "Position statement: nonanesthesiologist administration of propofol for GI endoscopy" issued by the four major gastroenterology and hepatology societies.
"These actions will expand even further the availability of a simple, rapid HIV test to communities where people are at high risk of HIV," Secretary Thompson said. "HIV testing has never been easier or more accessible than it is today.
Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, received a notice of allowance from the USPTO for a crucial patent covering its leading tumor-targeted vaccine technology for cancer immunotherapy. The issuance of this valuable patent protection for tumor targeted immunotherapy follows on the heels of two international patents covering targeted gene medicine in the U.S. and Europe, respectively, and places Epeius Biotech at the forefront of these emerging fields of clinical medicine with best-of-breed solutions and incontrovertible proofs-of-principle in the clinic.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Bradley Jenks Jr, PHD, LMFT 2185 N 500 E, North Logan, UT 84341-7800 Ph: () - | Dr David Bradley Jenks Jr, PHD, LMFT 2121 N 1700 W, Layton, UT 84041-8803 Ph: (801) 773-4840 |
News Archive
Tibotec Therapeutics announced today that the U.S. Food and Drug Administration (FDA) has approved a labeling update for PREZISTA® (darunavir) tablets to include 96-week data from the ARTEMIS and TITAN studies.
The worldwide safety experience of endoscopist-administered propofol sedation now exceeds 600,000 patients. The low rate of serious adverse events underscores the safety of nonanesthesiologist-administered propofol (NAAP) for gastrointestinal (GI) procedures, provided that it is administered by a team of individuals who have received training specific to the administration of propofol according to the "Position statement: nonanesthesiologist administration of propofol for GI endoscopy" issued by the four major gastroenterology and hepatology societies.
"These actions will expand even further the availability of a simple, rapid HIV test to communities where people are at high risk of HIV," Secretary Thompson said. "HIV testing has never been easier or more accessible than it is today.
Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, received a notice of allowance from the USPTO for a crucial patent covering its leading tumor-targeted vaccine technology for cancer immunotherapy. The issuance of this valuable patent protection for tumor targeted immunotherapy follows on the heels of two international patents covering targeted gene medicine in the U.S. and Europe, respectively, and places Epeius Biotech at the forefront of these emerging fields of clinical medicine with best-of-breed solutions and incontrovertible proofs-of-principle in the clinic.
› Verified 7 days ago
Ms. Marilyn D Stephens-burton, LMFT, M.A Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 930 W Hill Field Road, Suite A, Layton, UT 84041 Phone: 801-336-3040 Fax: 801-336-3041 | |
Brian Reeves, LAMFT Couples Therapy Medicare: Medicare Enrolled Practice Location: 934 S Main St, Layton, UT 84041 Phone: 801-336-1845 | |
Matthew Lefthand, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1730 E 3100 N Ste 2, Layton, UT 84040 Phone: 801-458-0665 | |
Nefily Ledezma, LMFT Couples Therapy Medicare: Medicare Enrolled Practice Location: 934 S Main St, Layton, UT 84041 Phone: 801-773-7060 Fax: 801-336-1787 | |
Daniel Stuart, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 930 W Hill Field Rd, Layton, UT 84041 Phone: 801-913-8790 | |
Amanda Van Leeuwen Jenks, MFT INTERN Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1660 W Antelope Dr Ste 301, Layton, UT 84041 Phone: 435-213-9278 | |
Alexis Anne Lee, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1650 W Gentile St, Layton, UT 84041 Phone: 801-485-8051 |